Home > BRISA > Search result
COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 2

Aripiprazol para el tratamiento de trastornos afectivos, del comportamiento o de la personalidad

Perú. Ministerio de Salud. Instituto Nacional de Salud.
INTRODUCCIÓN: Este documento técnico se realiza a solicitud del Instituto Nacional de Salud Mental “Honorio Delgado – Hideyo Noguchi”; la cual motivó la realización de la pregunta PICO por parte de médicos y especialistas de la siguiente manera, P: Pacientes con esquizofrenia, manía asociada ...
Mood Disorders/drug therapy, Aripiprazole/therapeutic use, Technology Assessment, Biomedical, Cost-Benefit Analysis, Peru
Fulltext

Aripiprazol comprimidos en tratamiento de la esquizofrenia

Hasdeu, Santiago; Fontana, Marcela.
CONTEXTO: La esquizofrenia es una enfermedad crónica y discapacitante que afecta aproximadamente al 1% de la población mundial. Representa una importante carga de enfermedad para los sistemas de salud y la sociedad en general. El tratamiento farmacológico incluye a los antipsicóticos típicos como el...
Aripiprazole/therapeutic use, Antipsychotic Agents/therapeutic use, Schizophrenia/drug therapy, Technology Assessment, Biomedical, Cost-Benefit Analysis
Fulltext